全球良性前列腺增生治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

良性摄护腺增生 (BPH) 治疗市场规模预计将从 2025 年的 24.6 亿美元成长到 2034 年的 55.3 亿美元，2026 年至 2034 年的复合年增长率为 9.41%。

由于男性人口老化和摄护腺健康意识提升的提高，全球良性摄护腺增生（BPH）治疗市场正稳定成长。诊断率的提高和泌尿系统医疗服务可近性的改善进一步推动了治疗需求。药物治疗和微创手术持续受到关注，促进了已开发地区和新兴地区市场的扩张。

关键成长要素包括微创手术技术的进步、联合药物疗法的改进以及医疗保健支出的增加。患者越来越倾向于选择恢復期较短的门诊治疗，这推动了医疗设备的普及。此外，加强宣传活动和定期健康检查也有助于早期诊断和提高患者对持续治疗的接受度。

随着医疗设备和药物疗法的不断创新，未来前景依然乐观。先进雷射治疗和非侵入性治疗方法的发展有望改善患者的治疗效果。专注于提供经济高效且以患者为中心的解决方案，并拓展新兴市场业务的公司，可望稳步成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球良性摄护腺增生治疗市场：依治疗方法

• 市场分析、洞察与预测
• 微创手术
• 侵入性手术

第五章 全球良性摄护腺增生治疗市场：依治疗方法

• 市场分析、洞察与预测
• 经尿道前列腺切除术
• 摄护腺雷射手术
• 经尿道微波热疗
• 经尿道摄护腺针消融术
• 前列腺尿道提升术
• 蒸气疗法
• 机器人辅助腹腔镜根治性摄护腺切除术
• 水磨疗法
• 摄护腺动脉栓塞术
• 开腹摄护腺切除术
• 双极摄护腺切除术
• 经尿道切口
• 高强度聚焦超音波

第六章 全球良性前列腺增生治疗市场：依产品分类

• 市场分析、洞察与预测
• 电切镜
• 泌尿系统雷射
• 射频消融疗法
• 电极
• 导管
• 摄护腺支架
• 植入
• 其他的

第七章 全球良性摄护腺增生治疗市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 专业设施
• 研究与製造

第八章 全球良性摄护腺增生治疗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Karl Storz
  • Boston Scientific Corporation
  • Olympus America
  • Endo Pharmaceuticals Inc
  • Biolitec AG
  • Medifocus
  • Cook Medical
  • Teleflex Incorporated
  • Urotronic
  • Coloplast Corp
  • Richard Wolf GmbH

The Benign Prostatic Hyperplasia Treatment Market size is expected to reach USD 5.53 Billion in 2034 from USD 2.46 Billion (2025) growing at a CAGR of 9.41% during 2026-2034.

The Global Benign Prostatic Hyperplasia Treatment Market is growing steadily due to the increasing aging male population and rising awareness of prostate health. Higher diagnosis rates and improved access to urological care have strengthened treatment demand. Pharmaceutical therapies and minimally invasive procedures continue to gain traction, contributing to market expansion across both developed and emerging regions.

Key drivers include technological advancements in minimally invasive surgical procedures, improved combination drug therapies, and rising healthcare spending. Greater patient preference for outpatient treatments with shorter recovery times is encouraging device adoption. Increased awareness campaigns and routine health screenings also contribute to early diagnosis and consistent treatment uptake.

Future prospects remain positive as innovation in medical devices and pharmacological treatments continues. Development of advanced laser therapies and non-invasive treatment options is expected to enhance patient outcomes. Companies focusing on cost-effective, patient-friendly solutions and expanding presence in emerging markets are likely to experience steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment

• Minimal Invasive Surgery
• Invasive Surgery

By Procedure

• Transurethral Resection Of The Prostate
• Prostate Laser Surgery
• Transurethral Microwave Thermotherapy
• Transurethral Needle Ablation Of The Prostate
• Prostatic Urethral Lift
• Water Vapor Therapy
• Robot-assisted Laparoscopic Prostatectomy
• Aquablation Therapy
• Prostatic Artery Embolization
• Open Prostatectomy
• Bipolar Enucleation Of Prostate
• Transurethral Incision Of The Prostate
• High-Intensity Focused Ultrasound

By Product

• Resectoscopes
• Urology Laser
• Radiofrequency Ablation
• Electrodes
• Catheters
• Prostatic Stents
• Implants
• Others

By End-use

• Hospitals
• Specialty Facilities
• Research & Manufacturing

COMPANIES PROFILED

• Karl Storz, Boston Scientific Corporation, Olympus America, Endo Pharmaceuticals Inc, biolitec AG, Medifocus, Cook Medical, Teleflex Incorporated, Urotronic, Coloplast Corp, Richard Wolf GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment
• 4.2. Minimal Invasive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Invasive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Transurethral Resection Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Prostate Laser Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transurethral Microwave Thermotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Transurethral Needle Ablation Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Prostatic Urethral Lift Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Water Vapor Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Robot-assisted Laparoscopic Prostatectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Aquablation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Prostatic Artery Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Open Prostatectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Bipolar Enucleation Of Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Transurethral Incision Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.14. High-Intensity Focused Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. Resectoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Urology Laser Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Radiofrequency Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Electrodes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Prostatic Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research & Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Treatment
  • 8.2.2 By Procedure
  • 8.2.3 By Product
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Treatment
  • 8.3.2 By Procedure
  • 8.3.3 By Product
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Treatment
  • 8.4.2 By Procedure
  • 8.4.3 By Product
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Treatment
  • 8.5.2 By Procedure
  • 8.5.3 By Product
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Treatment
  • 8.6.2 By Procedure
  • 8.6.3 By Product
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Karl Storz
  • 10.2.2 Boston Scientific Corporation
  • 10.2.3 Olympus America
  • 10.2.4 Endo Pharmaceuticals Inc
  • 10.2.5 Biolitec AG
  • 10.2.6 Medifocus
  • 10.2.7 Cook Medical
  • 10.2.8 Teleflex Incorporated
  • 10.2.9 Urotronic
  • 10.2.10 Coloplast Corp
  • 10.2.11 Richard Wolf GmbH